Chief Medical Officer · NEUROCRINE BIOSCIENCES INC · NEUROCRINE BIOSCIENCES INC — Restricted Stock Unit
Side
A
Value
—
Shares
1,506
Price
—
Executed
Nov 4, 2026
Disclosed
Nov 5, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 4 executedNov 5, 2026 disclosed
NBIX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
NEUROCRINE BIOSCIENCES INC — Restricted Stock Unit
Ticker
NBIX
Shares
1,506
Price per share
$0
Execution date (reported)
Nov 4, 2026
Owned after transaction
1,506 shares
Days from execution to publication
1
What this establishes
Roberts Eiry filed this Form 4 reporting a grant or award of NBIX on Nov 4, 2026. It became public on Nov 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Roberts Eirycik:0001727606
Issuer
NEUROCRINE BIOSCIENCES INCcik:0000914475
Revision history · 0
No field has changed since this record was first ingested.
